Apnimed, Inc. (APMD) Revenue, Earnings & Financial Statements
$17.34NASDAQ: APMDMarket Cap $721.78M
Data as of Nov 17, 2026 (intraday, delayed) · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
Apnimed, Inc. most recently reported annual revenue of $38.0M, a net loss of $1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Income Statement — 1 Years (USD millions)
Metric
2025
Revenue
$38.0M
Operating Expenses
$92.0M
Operating Profit
−$54.0M
Operating Margin
-139.9%
Other Income
$53.0M
Interest
$0
Depreciation
$0
Profit Before Tax
−$1.0M
Tax rate (%)
0.0%
Net Profit
−$1.0M
EPS
−$0.03
Quarterly Results — Last 3 Quarters (USD millions)
Metric
Mar '26
Jun '26
Sep '26
Revenue
$85.0M
$12.0M
$0
Operating Expenses
$17.0M
$24.0M
$32.0M
Operating Profit
$68.0M
−$12.0M
−$32.0M
Operating Margin
80.2%
-96.9%
—
Interest
$0
$0
$0
Profit Before Tax
$70.0M
$126.0M
−$30.0M
Tax rate (%)
0.0%
0.0%
0.0%
Net Profit
$70.0M
$126.0M
−$30.0M
EPS
$2.12
$3.16
−$1.05
Balance Sheet — 1 Years (USD millions)
Metric
2025
Total Assets
$73.0M
Current Assets
$45.0M
Cash
$42.0M
Inventory
$0
Receivables
$1.0M
Fixed Assets
$1.0M
Capital Work in Progress
$0
Investments
$0
Other Assets
$0
Total Liabilities
$446.0M
Current Liabilities
$111.0M
Borrowings
$42.0M
Other Liabilities
$404.0M
Equity
$0
Reserves
−$373.0M
Cash Flow Statement — 1 Years (USD millions)
Metric
2025
Operating Cash Flow
−$78.0M
Investing Cash Flow
$0
Financing Cash Flow
$0
Net Cash Flow
−$26.0M
Free Cash Flow
−$78.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
0.04
EV / EBITDA
16.96
FCF Yield
-8.19%
Quick Ratio
9.77
Interest Coverage
—
Return 1Y
—
Return 3Y
—
Return 5Y
—
Apnimed, Inc. (APMD) financials — frequently asked questions
What is Apnimed, Inc.'s annual revenue?
Apnimed, Inc. (APMD) reported annual revenue of $38.0M in its most recent fiscal year.
What is Apnimed, Inc.'s net profit?
Apnimed, Inc. (APMD) reported a net loss of $1.0M in its most recent fiscal year.
What is APMD EV/EBITDA?
Apnimed, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 16.96.
Revenue and earnings of other Biotechnology stocks